Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) Receivables

The latest receivables for SRNGU is $20M as of March 2026. That compares with $27M in the prior-year period — down 27.1% year over year. Investors often review this figure alongside Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, SRNGU's receivables moved from $27M to $20M — a 27.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s operating scale or balance-sheet position.

A receivables figure of $20M for SRNGU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SRNGU's receivables ($20M), review year-over-year change from $27M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s receivables against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.